Market Overview The global epinephrine market reached a size of USD 2436.69 Million in 2020, with an anticipated revenue Compound Annual Growth Rate (CAGR) of 8.4% throughout the forecast period. Key drivers for this growth include the increasing prevalence of anaphylaxis and the rising demand for epinephrine injections to address conditions such as cardiac arrest, asthma, and various other diseases.

Market Drivers The diverse effects of epinephrine on different body parts, such as the liver, skin, lungs, and heart, contribute to its increasing demand in the pharmaceutical industry. With a growing incidence of anaphylaxis worldwide, the ability of epinephrine to relieve symptoms by widening bronchial tubes is a significant factor fueling market demand. The prevalence of anaphylaxis is notably rising, with the UK alone registering an estimated 20 deaths due to this condition.

Epinephrine, also known as adrenaline, is a hormone secreted by the adrenal gland, playing a crucial role in synthesizing glycogen and maintaining cardiovascular homeostasis. It is widely used to treat severe allergic reactions like anaphylaxis, characterized by symptoms such as skin redness, difficulty in breathing, and accelerated heart rate.

Get a sample copy of the Epinephrine Market report: https://www.reportsanddata.com/download-free-sample/91

Moreover, the fight-or-flight response, wherein epinephrine elevates blood flow to muscles, underscores its importance. Manufacturers are focusing on various administration routes, including intravenous injection and inhalation, leading to the development of devices like epinephrine auto-injectors for quick emergency response. The market is witnessing increased product approvals and launches by major players.

Market Restraints Despite its effectiveness, adverse effects like high blood pressure, abnormal heart rhythm, headache, and anxiety associated with epinephrine have led doctors to recommend alternative pharmacotherapy or immunotherapy for severe allergic reactions. Limited research and development (R&D) expenditure on expanding the epinephrine pipeline is also a restricting factor for market growth.

Key Insights Product Type Breakdown: The market is segmented into auto-injectors, prefilled syringes, and ampoules and vials. Auto-injectors accounted for the largest revenue share in 2020, driven by the increasing demand for quick-response delivery routes and the rapid launch of affordable generic epinephrine products.

Application Breakdown: Anaphylaxis was the leading application segment in 2020, with a growing prevalence of anaphylactic allergic reactions globally. The demand for epinephrine treatment is rising to reduce the incidence of allergic reactions among an increasing number of individuals.

Distribution Channel Breakdown: The market is divided into hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies are expected to register the fastest revenue CAGR between 2021 and 2028, supported by increasing patient visits due to severe allergic conditions and rising prevalence of cardiac and lung diseases.

Regional Outlook: North America led the global epinephrine market in 2020, driven by the increasing number of people suffering from life-threatening food allergies, a robust healthcare infrastructure, and advanced medical facilities. The Asia Pacific region is anticipated to register the fastest revenue growth, with increasing awareness of treatment effectiveness against life-threatening allergies and high adoption rates of epinephrine injectors.

Companies Profiled: Key players in the market include Pfizer Inc., Mylan N.V, Teva Pharmaceuticals, Henry Schein Medical, Adamis Pharmaceuticals Corporation, Sandoz International GmbH, and Bausch Health Companies. Major companies are adopting both organic and inorganic growth strategies to maintain a competitive edge, including product launches, partnerships, agreements, collaborations, and expansions.

Customization Scope: The report offers 10 hours of free customization and expert consultation to meet specific requirements and provide valuable insights.

Explore Trending Reports:

Cardiac Surgery Instruments Market-https://www.globenewswire.com/news-release/2020/01/28/1976214/0/en/Cardiac-surgery-instruments-Market-To-Reach-USD-2-06-Billion-By-2027-Reports-And-Data.html

Respiratory Care Devices Market-https://www.globenewswire.com/news-release/2020/04/02/2011057/0/en/Respiratory-Care-Devices-Market-To-Reach-USD-37-04-Billion-By-2027-Reports-and-Data.html

Proteomics Market-https://www.globenewswire.com/en/news-release/2021/02/02/2168584/0/en/Proteomics-Market-Size-to-Reach-USD-57-57-Billion-By-2027-Surge-in-Genetic-and-Chronic-Diseases-and-Advancements-in-Technology-are-Key-Factors-Driving-Growth-of-Proteomics-Industry.html

Wearable Healthcare/Medical Devices Market-https://www.globenewswire.com/news-release/2019/02/27/1743565/0/en/Wearable-Healthcare-Medical-Devices-Market-To-Reach-USD-27-49-Billion-By-2026-CAGR-18-5-Reports-And-Data.html

Request a customization of the report: https://www.reportsanddata.com/request-customization-form/91

Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.

About Reports and Data    

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report

Browse Latest Blogs: https://www.reportsanddata.com/blogs

Browse Latest Press Release: https://www.reportsanddata.com/press-release